Articles From: Zillow Tech Connect Now Has 25 Technology Partners to ZIOPHARM Announces Expansion of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon and Clinical Program Update


2014/7/15
More than 100,000 contacts have passed through the program since November 2013 SEATTLE , July 15, 2014 /PRNewswire/ -- Zillow, Inc. (NASDAQ: Z) , the leading real estate information marketplace, today announced that Zillow® Tech Connect has surpassed 25 partners.
Sign-up for Zillow Tech Connect Now Has 25 Technology Partners investment picks
2014/7/21
MyNewPlace to get Zillow's multifamily listing inventory; Zillow to offer RealPage's real-time price, availability and Live Agent Service to rental customers SEATTLE , July 21, 2014 /PRNewswire/ -- Zillow, Inc. (NASDAQ: Z) , the leading real estate and home-related marketplace, today announced a new partnership with RealPage (NASDAQ: RP) , a leading provider of on-demand property management software, to help connect multifamily companies with new residents.
Sign-up for Zillow to Bring RealPage Services to Rental Companies investment picks
By Michael Calia Zillow Inc. has reached a deal to buy rival Trulia Inc., an expected agreement that brings together two of the biggest names in the fast-growing market for online real-estate information.
Sign-up for Zillow to buy real-estate rival Trulia investment picks
NEW YORK (MarketWatch) -- Real estate website Zillow Inc. (ZILLOW.XX) said it's buying Trulia Inc. (TRLA) for $3.5 billion in stock.
Sign-up for Zillow to buy Trulia for $3.5 bln in stock investment picks
2014/6/23
"The Big Picture: A Longer Term Perspective on Housing" Scheduled for Jul.
Sign-up for Zillow to Host Housing Forum in Washington, D.C. investment picks
2014/7/22
"The Big Picture: A Longer Term Perspective on Housing" Scheduled for Jul.
Sign-up for Zillow to Host Housing Forum in Washington, D.C.; Featured Speakers Include Jason Furman and Rep. Ed Perlmutter investment picks
2014/7/25
SEATTLE, July 25, 2014 (GLOBE NEWSWIRE) -- Zillow, Inc. (Nasdaq:Z) , the leading real estate information marketplace, today announced that Zillow® executives will participate in the following August investor conferences: About Zillow, Inc. Zillow, Inc. (Nasdaq:Z) operates the leading real estate and home-related marketplaces on mobile and the Web, with a complementary portfolio of brands and products that help people find vital information about homes, and connect with the best local professionals.
Sign-up for Zillow to Participate in August Investor Conferences investment picks
2014/8/28
SEATTLE, Aug.
Sign-up for Zillow to Participate in September Investor Conferences investment picks
2014/8/5
Record quarterly Revenue of $78.7 million, up 68% over second quarter 2013.
Sign-up for Zillow, Inc. Reports Record Second Quarter 2014 Results, Raises Full Year Outlook investment picks
SEATTLE and SAN FRANCISCO , Sept.
Sign-up for Zillow, Trulia receive second request for information from FTC investment picks
Zillow, Inc. (NASDAQ: Z) and Trulia, Inc. (NYSE: TRLA) announced today that they each received a Request for Additional Information, or a "second request," from the United States Federal Trade Commission (FTC) in connection with the FTC's review of Zillow’s proposed acquisition of Trulia under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the Act). This second request from the FTC is a standard part of the full regulatory process.
Sign-up for Zillow, Trulia Receive Second Request for Information from FTC investment picks
NEW YORK (MarketWatch) -- Shares of real estate websites Zillow Inc. (ZILLOW.XX) and Trulia Inc. (TRLA) surged in afternoon trade Thursday, after Bloomberg said Zillow is seeking to buy Trulia, citing people with knowledge of the matter.
Sign-up for Zillow, Trulia shares surge on report Zillow seeks to buy smaller rival investment picks
SAN FRANCISCO (MarketWatch) -- Online real-estate brokers were in the tech spotlight Monday, as Zillow Inc. (ZILLOW.XX) said it would acquire rival Trulia Inc. (TRLA) for $3.5 billion in an all-stock deal.
Sign-up for Zillow's $3.5 billion Trulia deal takes tech-stocks spotlight investment picks
Zilog, Inc., a wholly-owned subsidiary of IXYS Corporation (NASDAQ:IXYS) and a pioneer supplier of microcontrollers (MCUs) providing solutions for the industrial, telecommunication, automotive and consumer markets, introduces a Z8F2480-based AC power monitor with an eZ80F91 Webserver, expanding its portfolio of reference designs and fast time-to-market solutions.
Sign-up for Zilog Announces Z8F2480 Power Monitor with eZ80F91 Webserver Reference Design investment picks
2014/8/27
WARSAW, Ind.
Sign-up for Zimmer Holdings to Present at Morgan Stanley 2014 Global Healthcare Conference investment picks
2014/7/2
WARSAW, Ind.
Sign-up for Zimmer Holdings, Inc. and Biomet, Inc. Receive Requests for Additional Information from FTC investment picks
2014/8/26
WARSAW, Ind.
Sign-up for Zimmer Holdings, Inc. Announces Quarterly Dividend for Third Quarter of 2014 investment picks
2014/7/24
- Net Sales of $1.18 billion represent an increase of 1.2% reported over the prior year period (an increase of 0.9% constant currency) - Diluted EPS for the second quarter were $1.03 reported, an increase of 15.7% over the prior year period, and $1.49 adjusted, an increase of 4.2% over the prior year period - Company updates sales and earnings guidance for full-year 2014 WARSAW, Ind.
Sign-up for Zimmer Holdings, Inc. Reports Second Quarter 2014 Financial Results investment picks
2014/7/21
Retail Specialist Zimmerman Advertising Wins Lucky Brand Out of LA FORT LAUDERDALE, Fla.
Sign-up for Zimmerman Gets Lucky investment picks
SALT LAKE CITY , July 28, 2014 /PRNewswire/ -- Zions Bancorporation (NASDAQ: ZION) ("Zions") announced today that it has commenced a public offering of $525 million of its common stock pursuant to a prospectus supplement dated July 28, 2014 to its prospectus dated April 21 , 2014.
Sign-up for Zions Bancorporation Announces $525 Million Common Stock Offering investment picks
2014/7/28
SALT LAKE CITY , July 28, 2014 /PRNewswire/ -- Zions Bancorporation ("Zions") announced today that it has priced its public offering of $525 million of its common stock.
Sign-up for Zions Bancorporation Announces Pricing of $525 Million Common Stock Offering investment picks
SALT LAKE CITY , July 18, 2014 /PRNewswire/ -- Zions Bancorporation (NASDAQ: ZION) announced today that its board of directors declared a regular quarterly dividend of $0.04 per common share.
Sign-up for Zions Bancorporation Board Declares Dividends For Common And Preferred Shares investment picks
SALT LAKE CITY , July 18, 2014 /PRNewswire/ -- Zions Bancorporation (Nasdaq: ZION) today announced that Edward F.
Sign-up for Zions Bancorporation Elects Edward F. Murphy To Its Board Of Directors investment picks
SALT LAKE CITY , Aug.
Sign-up for Zions Bancorporation Elects John C. Erickson To Its Board Of Directors investment picks
SALT LAKE CITY , July 21, 2014 /PRNewswire/ -- Zions Bancorporation (NASDAQ: ZION) ("Zions" or "the Company") today reported second quarter net earnings applicable to common shareholders of $104.5 million , or $0.56 per diluted common share, compared to $76.2 million , or $0.41 per diluted share for the first quarter of 2014, and $55.4 million , or $0.30 per diluted share for the second quarter of 2013.
Sign-up for Zions Bancorporation Reports Earnings Of $0.56 Per Diluted Common Share For Second Quarter 2014 investment picks
SALT LAKE CITY , Sept.
Sign-up for Zions Bancorporation To Present At The Barclays Global Financial Services Conference investment picks
SALT LAKE CITY , July 1, 2014 /PRNewswire/ -- Zions Bancorporation (Nasdaq: ZION) announced today that it will report its second quarter 2014 earnings results after the NASDAQ close on Monday, July 21, 2014 .
Sign-up for Zions Bancorporation To Report Second Quarter 2014 Earnings Results investment picks
Expansion of synthetic immuno-oncology programs to include chimeric antigen receptor T-cell (CAR-T) therapy Increased applications of RheoSwitch ® platform and its unique capabilities into targeted cellular oncology products Phase I trial utilizing Ad-RTS-IL-12 in Glioblastoma Multiforme expected to launch in 2H2014 BOSTON and GERMANTOWN, Md., July 22, 2014 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. ("ZIOPHARM") (Nasdaq:ZIOP) , a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced the expansion of synthetic immuno-oncology programs in conjunction with Intrexon Corporation (NYSE:XON) to include chimeric antigen receptor T-cell (CAR-T) therapy.
Sign-up for ZIOPHARM Announces Expansion of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon and Clinical Program Update investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Zillow Tech Connect Now Has 25 Technology Partners to ZIOPHARM Announces Expansion of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon and Clinical Program Update
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices